Inhibitor

Bibliography

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Inhibitor Report for: Melatonin-alkylbenzylamine-Cpd5

huBuChE IC(50)=1.20 microM, huAChE IC(50) = 177.49 microM


General
Type Antioxidant, Derivative of Tryptamine, Multitarget, Alkyl linked bis-ligand
Chemical_Nomenclature 5-hydroxy-1-(12-((3-hydroxybenzyl)(methyl)amino)dodecyl)-1H-indole-3-carbaldehyde
Canonical SMILES C(CCCCCCCCN(CC1=CC(=CC=C1)O)C)CCC[N]3C2=CC=C(C=C2C(=C3)C=O)O
InChI InChI=1S/C29H40N2O3/c1-30(21-24-13-12-14-26(33)19-24)17-10-8-6-4-2-3-5-7-9-11-18-31-22-25(23-32)28-20-27(34)15-16-29(28)31/h12-16,19-20,22-23,33-34H,2-11,17-18,21H2,1H3
InChIKey FSMMMQWAIKAMQM-UHFFFAOYSA-N
Other name(s)
________________________________________________________________________________________________
MW|465.31
Formula|C29H40N2O3
CAS_number|
PubChem|
UniChem|FSMMMQWAIKAMQM-UHFFFAOYSA-N
IUPHAR|
Wikipedia|

Target
Families | Melatonin-alkylbenzylamine-Cpd5 ligand of proteins in family: 'BCHE"

References:
Search PubMed for references concerning: Melatonin-alkylbenzylamine-Cpd5
    Title: Dual functional antioxidant and butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease: Design, synthesis and evaluation of novel melatonin-alkylbenzylamine hybrids
    Liu P, Cheng M, Guo J, Cao D, Luo J, Wan Y, Fang Y, Jin Y, Xie SS, Liu J
    Ref: Bioorganic & Medicinal Chemistry, 78:117146, 2023 : PubMed